| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA3534323 | A | Drug metabolism in human liver assessed as N-carbamoyl glucuronide formation per mg protein at 100 uM | Homo sapiens | 1 | ALA3525961 | tissue-based format | Scientific Literature | |
| 2. | ALA3534324 | A | Drug metabolism in human kidney assessed as N-carbamoyl glucuronide formation per mg protein at 100 uM | Homo sapiens | 1 | ALA3525961 | tissue-based format | Scientific Literature | |
| 3. | ALA3534325 | A | Drug metabolism in human intestine assessed as N-carbamoyl glucuronide formation per mg protein at 100 uM | Homo sapiens | 1 | ALA3525961 | tissue-based format | Scientific Literature | |
| 4. | ALA3534326 | A | Drug metabolism in smoking human lung assessed as N-carbamoyl glucuronide formation per mg protein at 100 uM | Homo sapiens | 1 | ALA3525961 | tissue-based format | Scientific Literature | |
| 5. | ALA3534327 | A | Drug metabolism in non-smoking human lung assessed as N-carbamoyl glucuronide formation per mg protein at 100 uM | Homo sapiens | 1 | ALA3525961 | tissue-based format | Scientific Literature | |
| 6. | ALA3534328 | A | Activity of human recombinant UGT1A6 expressed in insect cells assessed as intrinsic clearance for enzyme-mediated N-carbamoyl glucuronide formation | Homo sapiens | 1 | ALA3525961 | cell-based format | Scientific Literature | |
| 7. | ALA3534329 | A | Activity of human recombinant UGT1A9 expressed in insect cells assessed as intrinsic clearance for enzyme-mediated N-carbamoyl glucuronide formation | Homo sapiens | 1 | ALA3525961 | cell-based format | Scientific Literature | |
| 8. | ALA3534330 | A | Activity of human recombinant UGT2B7 expressed in insect cells assessed as intrinsic clearance for enzyme-mediated N-carbamoyl glucuronide formation | Homo sapiens | 1 | ALA3525961 | cell-based format | Scientific Literature | |
| 9. | ALA3534331 | A | Activity of human recombinant UGT2B15 expressed in insect cells assessed as intrinsic clearance for enzyme-mediated N-carbamoyl glucuronide formation | Homo sapiens | 1 | ALA3525961 | cell-based format | Scientific Literature | |
| 10. | ALA3534332 | A | Activity of human recombinant UGT2B17 expressed in insect cells assessed as intrinsic clearance for enzyme-mediated N-carbamoyl glucuronide formation | Homo sapiens | 1 | ALA3525961 | cell-based format | Scientific Literature | |
| 11. | ALA3534333 | A | Drug excretion in human urine | Homo sapiens | 1 | ALA3525961 | tissue-based format | Scientific Literature | |
| 12. | ALA3534334 | A | Drug excretion in human urine assessed as N-carbamoyl glucuronide formation | Homo sapiens | 1 | ALA3525961 | tissue-based format | Scientific Literature | |
| 13. | ALA3534335 | A | Drug metabolism in human liver microsomes assessed as 5 uM bisphenol-mediated inhibition of N-carbamoyl glucuronide formation at 1 uM | Homo sapiens | 1 | ALA3525961 | assay format | Scientific Literature | |
| 14. | ALA3534336 | A | Drug metabolism in human liver microsomes assessed as 20 uM eugenol-mediated inhibition of N-carbamoyl glucuronide formation at 1 uM | Homo sapiens | 1 | ALA3525961 | assay format | Scientific Literature | |
| 15. | ALA3534337 | A | Drug metabolism in human liver microsomes assessed as 5 uM mefenamic acid-mediated inhibition of N-carbamoyl glucuronide formation at 1 uM | Homo sapiens | 1 | ALA3525961 | assay format | Scientific Literature | |
| 16. | ALA3534338 | A | Drug metabolism in human liver microsomes assessed as inhibition of N-carbamoyl glucuronide formation at 1 uM in presence of 5 uM mefenamic acid and 5 uM bisphenol and 20 uM eugenol | Homo sapiens | 1 | ALA3525961 | assay format | Scientific Literature | |
| 17. | ALA3534339 | A | Drug metabolism in human liver microsomes assessed as 25 uM mefenamic acid-mediated inhibition of N-carbamoyl glucuronide formation at 1 uM | Homo sapiens | 1 | ALA3525961 | assay format | Scientific Literature | |
| 18. | ALA3534340 | A | Drug metabolism in human liver microsomes assessed as 25 uM bisphenol-mediated inhibition of N-carbamoyl glucuronide formation at 1 uM | Homo sapiens | 1 | ALA3525961 | assay format | Scientific Literature | |
| 19. | ALA3534341 | A | Drug metabolism in human liver microsomes assessed as 100 uM eugenol-mediated inhibition of N-carbamoyl glucuronide formation at 1 uM | Homo sapiens | 1 | ALA3525961 | assay format | Scientific Literature | |
| 20. | ALA3534661 | A | Drug metabolism in human liver microsomes assessed as inhibition of N-carbamoyl glucuronide formation at 1 uM in presence of 25 uM mefenamic acid and 25 uM bisphenol and 100 uM eugenol | Homo sapiens | 1 | ALA3525961 | assay format | Scientific Literature |
The page will load shortly, Thanks for your patience!